Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.

Current prostate cancer tests may fail to detect early-stage disease in transgender women, potentially leading to delayed diagnosis and treatment.

A recent study published in the Journal of the American Medical Association (JAMA) has shed new light on prostate-specific antigen (PSA) values among...

New study cautions transgender women and physicians to approach standard screening guidelines with caution. Hormone therapy in transgender women can...

With NIH funding, a new study aims to better detect early-stage diseases such as cancer and dementia.

Transgender women continue to face the risk of developing prostate cancer. A recent study conducted by Cedars-Sinai Cancer researchers, published in...

Blood tests offer a promising method to predict a person's risk of developing obstructive sleep apnea by measuring levels of specific biomarkers.

UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of...

A National Institutes of Health (NIH) grant received by Xiaohu Xia based on his nanoparticle research aims to facilitate early detection of...